ATE241375T1 - Verwendung eines serenoa repens extraktes zur herstellung eines arzneimittels zur behandlung von krebserkrankungen der prostata - Google Patents

Verwendung eines serenoa repens extraktes zur herstellung eines arzneimittels zur behandlung von krebserkrankungen der prostata

Info

Publication number
ATE241375T1
ATE241375T1 AT00915254T AT00915254T ATE241375T1 AT E241375 T1 ATE241375 T1 AT E241375T1 AT 00915254 T AT00915254 T AT 00915254T AT 00915254 T AT00915254 T AT 00915254T AT E241375 T1 ATE241375 T1 AT E241375T1
Authority
AT
Austria
Prior art keywords
production
prostate
treatment
serenoa repens
medicinal product
Prior art date
Application number
AT00915254T
Other languages
English (en)
Inventor
Pierre Fabre
Jean-Pierre Raynaud
Henri Cousse
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of ATE241375T1 publication Critical patent/ATE241375T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT00915254T 1999-03-30 2000-03-30 Verwendung eines serenoa repens extraktes zur herstellung eines arzneimittels zur behandlung von krebserkrankungen der prostata ATE241375T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9903959A FR2791573B1 (fr) 1999-03-30 1999-03-30 Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate
PCT/FR2000/000804 WO2000057892A1 (fr) 1999-03-30 2000-03-30 Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate

Publications (1)

Publication Number Publication Date
ATE241375T1 true ATE241375T1 (de) 2003-06-15

Family

ID=9543805

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00915254T ATE241375T1 (de) 1999-03-30 2000-03-30 Verwendung eines serenoa repens extraktes zur herstellung eines arzneimittels zur behandlung von krebserkrankungen der prostata

Country Status (15)

Country Link
US (1) US6599540B1 (de)
EP (1) EP1165108B1 (de)
JP (1) JP2003504306A (de)
CN (1) CN1261142C (de)
AT (1) ATE241375T1 (de)
AU (1) AU774568B2 (de)
BR (1) BR0009445A (de)
CA (1) CA2370775C (de)
DE (1) DE60003010T2 (de)
DK (1) DK1165108T3 (de)
ES (1) ES2199802T3 (de)
FR (1) FR2791573B1 (de)
MX (1) MXPA01009879A (de)
PT (1) PT1165108E (de)
WO (1) WO2000057892A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1488807A4 (de) * 2002-03-11 2009-07-08 Takeda Pharmaceutical Mittel zur behandlung von sexualhormonabhängigen erkrankungen
CN101098675B (zh) 2004-11-25 2013-04-10 墨尔本大学 稳定的磷酸钙复合物
US20060134243A1 (en) * 2004-12-17 2006-06-22 Bionovo, Inc. Method of using extracts of epimedium species
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
US8673363B2 (en) 2005-06-07 2014-03-18 The University Of Melbourne Dental mineralization
US8603988B2 (en) 2005-06-24 2013-12-10 The University Of Melbourne Ionic complexes
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
DK1986587T3 (en) 2006-02-09 2018-12-17 Univ Melbourne Toothpaste FLUORIDE COMPOSITION
US20080319051A1 (en) * 2007-06-22 2008-12-25 Bionovo, Inc. Liquiritigenin and derivatives as selective estrogen receptor beta agonists
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
AU2008285325A1 (en) * 2007-08-08 2009-02-12 Bionovo, Inc. Extracts of Ligustrum lucidum and uses thereof
AU2008296072A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of Astragalus membranaceus Fisch.Bge.Var.mongolicus Bge. of the Leguminosae Family and uses thereof
WO2009033103A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of pueraria lobata willd, ohwi of the leguminosae family and uses thereof
AU2008296136A1 (en) * 2007-09-07 2009-03-12 Bionovo. Inc. Estrogenic extracts of Scuttelaria barbata D. Don of the Labiatae Family and uses thereof
AU2008296176A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of Asparagus conchinchinensis (Lour.) Merr of the Liliaceae Family and uses thereof
US8512961B2 (en) * 2007-11-19 2013-08-20 Bionovo, Inc. Methods of detecting and treatment of cancers using Scutellaria barbata extract
US20090130118A1 (en) * 2007-11-19 2009-05-21 Bionovo, Inc. Scutellaria barbata extract and combinations for the treatment of cancer
CA2706315A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Anti-cancer therapy with an extract of scutellaria barbata
EP2222323A4 (de) * 2007-11-19 2012-07-25 Bionovo Inc Verfahren zur herstellung eines gereinigten extrakts von scutellaria barbata d. don
DE102008012988A1 (de) 2008-03-07 2009-09-10 S.W. Patentverwertungs Ltd. Zusammensetzung und Verwendungen zur Beeinflussung des Haarwachstums
CA2721191A1 (en) * 2008-04-14 2009-10-22 Bionovo, Inc. Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
AU2009244315A1 (en) * 2008-05-06 2009-11-12 Bionovo, Inc. Estrogenic extracts for use in treating vaginal and vulvar atrophy
US20090311349A1 (en) * 2008-06-05 2009-12-17 Bionovo, Inc., A Delaware Corporation Method of quantification of multiple bioactives from botanical compositions
CA2727018A1 (en) * 2008-06-06 2009-12-10 Bionovo, Inc. Anthraquinones and analogs from rhuem palmatum for treatment of estrogen receptor beta-mediated conditions
PL2310023T3 (pl) * 2008-07-31 2017-02-28 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Kompozycja zawierająca ekstrakt z zielonej herbaty i ekstrakt z granatów do stosowania w zapobieganiu lub ograniczeniu progresji raka prostaty
JP2012501974A (ja) * 2008-09-03 2012-01-26 バイオノボ・インコーポレーテッド 癌の処置のための方法および組成物
AU2010246233A1 (en) * 2009-04-28 2011-12-22 Bionovo, Inc. Method of reducing fat accumulation and inducing weight loss
FR2963561B1 (fr) 2010-08-03 2013-04-12 Pf Medicament Composition pharmaceutique contenant un extrait de serenoa repens
US10441561B2 (en) 2012-07-26 2019-10-15 The William M. Yanbrough Foundation Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
EP3024428B1 (de) 2013-07-23 2020-10-21 The University of Melbourne Zusammensetzungen und verfahren zur dentalen mineralisierung
PL3086751T3 (pl) 2013-12-24 2023-12-27 The University Of Melbourne Stabilizowane kompozycje cyny
CZ306733B6 (cs) * 2014-08-27 2017-05-31 Walmark, A.S. Doplněk stravy na bázi klikvy velkoplodé pro použití k oddálení biochemického návratu karcinomu prostaty
KR102555722B1 (ko) 2017-03-14 2023-07-13 더 유니버시티 오브 멜버른 감수성 치료용 복합체
MY197428A (en) 2017-03-14 2023-06-16 Univ Melbourne Treatment for gingivitis
BR112021018010A2 (pt) 2019-03-13 2021-11-23 Univ Melbourne Composições e métodos para promover mineralização

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2465486A1 (fr) * 1979-09-21 1981-03-27 Roussel Uclaf Nouvelle application utilisant la lh-rh ou des agonistes
FR2480754A1 (fr) * 1980-04-21 1981-10-23 Fabre Sa Pierre Procede d'obtention d'un extrait stable et desodorise de sabal serrulatum antiprostatique
IT1258305B (it) * 1992-04-10 1996-02-22 Zambeletti Spa L Composizioni farmaceutiche rettali per il trattamento dell'ipertrofia prostatica
US6039950A (en) * 1995-04-14 2000-03-21 University Of Southern California Pharmaceutical grade saw palmetto
US6107090A (en) * 1996-05-06 2000-08-22 Cornell Research Foundation, Inc. Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
US5665393A (en) * 1996-09-03 1997-09-09 International Medical Research, Inc. Herbal composition for treating prostate carcinoma
WO2000007604A1 (en) * 1998-08-03 2000-02-17 Wheeler Ronald E Prostate formula
US6399115B2 (en) * 1999-09-10 2002-06-04 Glenn Braswell Method and composition for the treatment of benign prostate hypertrophy (BPH) and prevention of prostate cancer
US6261607B1 (en) * 1999-10-19 2001-07-17 Thomas Newmark Composition for promoting prostate health containing selenium and herbal extracts
US6200573B1 (en) * 1999-12-03 2001-03-13 Starcor Pharmaceuticals, Inc. Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia

Also Published As

Publication number Publication date
AU3663100A (en) 2000-10-16
BR0009445A (pt) 2002-01-08
DE60003010D1 (de) 2003-07-03
DE60003010T2 (de) 2004-04-01
FR2791573A1 (fr) 2000-10-06
AU774568B2 (en) 2004-07-01
EP1165108A1 (de) 2002-01-02
US6599540B1 (en) 2003-07-29
FR2791573B1 (fr) 2003-04-11
CN1346277A (zh) 2002-04-24
PT1165108E (pt) 2003-10-31
WO2000057892A1 (fr) 2000-10-05
CA2370775C (fr) 2011-06-21
ES2199802T3 (es) 2004-03-01
CN1261142C (zh) 2006-06-28
CA2370775A1 (fr) 2000-10-05
MXPA01009879A (es) 2002-05-06
JP2003504306A (ja) 2003-02-04
DK1165108T3 (da) 2003-09-22
EP1165108B1 (de) 2003-05-28

Similar Documents

Publication Publication Date Title
DE60003010D1 (de) Verwendung eines serenoa repens extraktes zur herstellung eines arzneimittels zur behandlung von krebserkrankungen der prostata
DE60023476D1 (de) Kombination von doctaxel und rhumab her2 zür krebsbehandlung
NO20000752L (no) Metode for forhindring eller behandling av østrogen-avhengige sykdommer og forstyrrelser
MXPA03003960A (es) Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos.
FI963687A0 (fi) Hygieeniset ja kosmeettiset valmisteet ihosairauksien estämiseksi ja hoitamiseksi sekä menetelmä niiden valmistamiseksi
WO2002017852A3 (en) Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
DE60213386D1 (de) Geldanamycinderivate zur krebsbehandlung
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
WO2023164455A3 (en) Compositions and methods to modulate the immune system
AU2020327022A8 (en) Method of treating cancer
DE60116075D1 (de) Behandlung von tumoren mit photodynamischer therapie
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
DE60216292D1 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
DE60002552D1 (de) Verwendung von einem bpi protein zur herstellung eines medikamentes zur behandlung von chronischen herzerkrankungen
RU94024337A (ru) Антиметастатическое средство
ATE380555T1 (de) Behandlung von autoimmunkrankheiten mit einem extrakt von amerikanischem ginseng
MXPA05013827A (es) Composiciones que comprenden zd6126 junto con 5-fu, cpt-11 o 5-fu y cpt-11, que tienen actividad de dano vascular, para tratar cancer colorectal e. g.
DE59009724D1 (de) Verwendung von 7-oh-1,2-benzopyron zur herstellung eines arzneimittels zur behandlung von malignen tumoren beim menschen.
DE60122781D1 (de) Neue therapeutische verwendung eines derivates von thienylcyclohexylamine zur behandlung von schmerzen
DE60033540D1 (de) Verabreichung von gammaglobulinen zur behandlung von lymphomen
Pathak et al. REVIEW OF RASAYAN IN CANCER TREATMENT, A NEED OF THE MODERN ERA
KR20010089975A (ko) 캡사이신을 이용한 만성 전립선염, 전립선 비대증, 치질및 발기부전 치료제
DE59506911D1 (de) Verwendung von intravenös applizierbarem eisen zur therapie von tumorerkrankungen und/oder infektionskrankheiten
SHINOHARA et al. A Case of Chronic Nasal Obstruction Treated with Kampo Medicine and Acupuncture

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1165108

Country of ref document: EP